RxDoctor Payments Data

Kamal Joshi, MD

Clinical Cardiac Electrophysiology · Olympia, WANPI 1508020801

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 33.7% of the total.

$22,592in general payments, 2019–2025

Across 173 payments — averaging $130.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$8K
  • Biotronik Inc.$5K
  • Medtronic$4K
  • Medical Device Business Services, Inc.$3K
  • Biosense Webster, Inc.$2K
  • Abbott$151
  • plus $563 from 8 others

What the payments were for

  • Speaking & faculty fees$2,0009%
  • Travel & lodging$11,94553%
  • Food & beverage$8,55238%
  • Education$960%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,592 in reported general payments places this provider in the 70th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington

Medicare billing

Part B allowed, 2024
$377,219
Medicare patients
1,445
Services billed
4,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban343$314,787
XareltoRivaroxaban94$85,778
EntrestoSacubitril/Valsartan37$42,858
JardianceEmpagliflozin18$15,347
Metoprolol Succinate344$3,705
Flecainide Acetate114$2,957
Amiodarone Hcl54$1,919
Diltiazem 24hr Er (Cd)Diltiazem Hcl42$802
Pantoprazole Sodium113$732
Losartan Potassium63$444
Digoxin26$431
Carvedilol62$425
Furosemide115$403
Atorvastatin Calcium35$402
Rosuvastatin Calcium18$387

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →